Chemotherapy Palliation Carcinoma Partial Remission CTACAE Clinical stage Active surveillance Maintenance chemotherapy Pathological stage performance status Tyrosine kinase inhibitors (TKIs) Tumor Checkpoint inhibitor Neoadjuvant treatment Monoclonal antibody Adjuvant treatment Cellular therapy Definitive treatment Complementary therapy Antibody Drug Conjugate (ADCs) Relapse leukemia TNM staging system Recurrence Complete remission Sarcoma Grade 3, 4, or 5 Cure Adenocarcinoma Surgical margin Minimal residual disease (MRD) Refractory Maintenance chemotherapy ECOG performance status Chemotherapy Palliation Carcinoma Partial Remission CTACAE Clinical stage Active surveillance Maintenance chemotherapy Pathological stage performance status Tyrosine kinase inhibitors (TKIs) Tumor Checkpoint inhibitor Neoadjuvant treatment Monoclonal antibody Adjuvant treatment Cellular therapy Definitive treatment Complementary therapy Antibody Drug Conjugate (ADCs) Relapse leukemia TNM staging system Recurrence Complete remission Sarcoma Grade 3, 4, or 5 Cure Adenocarcinoma Surgical margin Minimal residual disease (MRD) Refractory Maintenance chemotherapy ECOG performance status
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Chemotherapy
Palliation
Carcinoma
Partial Remission
CTACAE
Clinical stage
Active surveillance
Maintenance chemotherapy
Pathological stage
performance status
Tyrosine kinase inhibitors (TKIs)
Tumor
Checkpoint inhibitor
Neoadjuvant treatment
Monoclonal antibody
Adjuvant treatment
Cellular therapy
Definitive treatment
Complementary therapy
Antibody Drug Conjugate (ADCs)
Relapse
leukemia
TNM staging system
Recurrence
Complete remission
Sarcoma
Grade 3, 4, or 5
Cure
Adenocarcinoma
Surgical margin
Minimal residual disease (MRD)
Refractory
Maintenance chemotherapy
ECOG performance status